Available Until 4/1/2025

Intrathecal Targeted Drug Delivery (ITDD)

ACPE Activity Number: 0204-0000-23-032-H01-P
Release Date: 04/01/2023
Expiration Date: 04/01/2025
Activity Type: Knowledge-based
CE Credits:  0.5 contact hour, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

Intrathecal targeted drug delivery (ITDD) is gaining momentum for use for chronic pain, refractory cancer pain, or treatment of pain in patients with opioid use disorders. As a result, pharmacists are asked to help with dosing conversions and adjustments of intrathecal pumps. Pharmacists lack knowledge of IT pumps and medications utilized for intrathecal delivery. With the most current information and effective practice strategies, pharmacists can improve their treatment of pain patients with IT pumps and determine appropriate candidacy for ITDD use. 

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These activities were planned to meet the educational needs of pharmacists who may encounter patients with an implanted intrathecal pump for pain management.  

After completing this activity, the learner should be able to…

  • Describe an intrathecal pump and its place in therapy.
  • List medications utilized in intrathecal pumps.
  • Discuss advantages and disadvantages of using intrathecal pumps. 

  • Introduction and Announcements 

  • Presentation  

Tanya J. Uritsky, PharmD
Opioid Stewardship Coordinator
Hospital of the University of Pennsylvania
Philadelphia, PA

Nikki Eye, PharmD 
Avera McKennan Hospital  
Sioux Falls, SD 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.